Routine

Primary aldosteronism (Conn's syndrome)

Endocrine · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

The commonest treatable secondary cause of hypertension, driven by autonomous aldosterone excess. Screen resistant or hypokalaemic hypertension with the aldosterone:renin ratio, distinguish a unilateral adenoma from bilateral hyperplasia, and treat with surgery or an MRA. First action: aldosterone:renin ratio (off interfering drugs where possible).

Red flags

  • Refer to endocrinology for confirmation, subtyping (vein sampling) and management, particularly resistant, young-onset or hypokalaemic hypertension
  • Admit for severe hypokalaemia or hypertensive emergency

Assessment

Investigations

  • Aldosterone:renin ratio as the screening test (raised aldosterone with suppressed renin); withdraw/replace confounding antihypertensives and correct potassium first
  • Confirm with a suppression test (e.g. saline infusion)
  • Adrenal CT then adrenal vein sampling to lateralise before surgery
  • Screen for end-organ damage

Management

  • Unilateral disease: laparoscopic adrenalectomy can cure or markedly improve hypertension
  • Bilateral disease or non-surgical candidates: mineralocorticoid-receptor antagonist (spironolactone or eplerenone), titrated to BP and potassium
  • Monitor renal function and potassium; reinforce lifestyle measures

Disposition

Refer to endocrinology for confirmation, subtyping (vein sampling) and management, particularly resistant, young-onset or hypokalaemic hypertension.

Complications & pitfalls

  • Disproportionate cardiovascular and renal damage (stroke, MI, AF, LVH, CKD) from aldosterone excess, and severe hypokalaemia with arrhythmia

Exam pearls

  • Screen for primary aldosteronism in anyone with resistant hypertension or hypertension with unexplained (or diuretic-provoked) hypokalaemia — it's far commoner than taught, and a curable cause you'll miss if you don't check the aldosterone:renin ratio.
  • Monitoring & follow-up: Post-adrenalectomy BP, potassium and aldosterone to confirm response. On MRA therapy: BP, renal function and potassium, and manage anti-androgen side-effects of spironolactone (switch to eplerenone if troublesome).

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.